Insiders Updates
Immunome Inc [NASDAQ: IMNM] Sees Decrease in Stock Value
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25 ’25.
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Immunome Inc
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $60684.0 on Mar 25 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or